Wilmington's Sale of APM Will Lead to Long-Term Growth -- Market Talk

Like
Comment
Favorite

Wilmington's Sale of APM Will Lead to Long-Term Growth -- Market Talk

Dow Jones04-26

0830 GMT - Wilmington's sale of APM aligns with its strategic focus on portfolio businesses with common characteristics that drive the U.K. data and training-services provider's organic revenue growth and profitability, Numis analysts Steve Liechti and Gareth Davies write in a research note. The deal is part of a proposed healthcare intelligence assets sale and should lead to long-term growth and quality of earnings, the analysts say. As a result of the cash proceeds and the previous MiExact sale, full-year net cash will increase to GBP63 million, the U.K. brokerage says. Shares are up 2% at 359.00 pence.(najat.kantouar@wsj.com)

(END) Dow Jones Newswires

April 26, 2024 04:31 ET (08:31 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2430244914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-26 16:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2430244914","market":"sh","top_or_hot":-1,"title":"Wilmington's Sale of APM Will Lead to Long-Term Growth -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0830 GMT - Wilmington's sale of APM aligns with its strategic focus on portfolio businesses with common characteristics that drive the U.K. data and training-services provider's organic revenue growth and profitability, Numis analysts Steve Liechti and Gareth Davies write in a research note. The deal is part of a proposed healthcare intelligence assets sale and should lead to long-term growth and quality of earnings, the analysts say. As a result of the cash proceeds and the previous MiExact sale, full-year net cash will increase to GBP63 million, the U.K. brokerage says. Shares are up 2% at 359.00 pence.(najat.kantouar@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 26, 2024 04:31 ET (08:31 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wilmington's Sale of APM Will Lead to Long-Term Growth -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWilmington's Sale of APM Will Lead to Long-Term Growth -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-26 16:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>0830 GMT - Wilmington's sale of APM aligns with its strategic focus on portfolio businesses with common characteristics that drive the U.K. data and training-services provider's organic revenue growth...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APM","symbol_name":"知临集团","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2430244914","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430244914","pubTimestamp":1714120260,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0830 GMT - Wilmington's sale of APM aligns with its strategic focus on portfolio businesses with common characteristics that drive the U.K. data and training-services provider's organic revenue growth and profitability, Numis analysts Steve Liechti and Gareth Davies write in a research note. The deal is part of a proposed healthcare intelligence assets sale and should lead to long-term growth and quality of earnings, the analysts say. As a result of the cash proceeds and the previous MiExact sale, full-year net cash will increase to GBP63 million, the U.K. brokerage says. Shares are up 2% at 359.00 pence.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APM":"知临集团","BK4139":"生物科技"},"translate_title":"威尔明顿出售APM将带来长期增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APM":1},"content_text":"0830 GMT - Wilmington's sale of APM aligns with its strategic focus on portfolio businesses with common characteristics that drive the U.K. data and training-services provider's organic revenue growth and profitability, Numis analysts Steve Liechti and Gareth Davies write in a research note. The deal is part of a proposed healthcare intelligence assets sale and should lead to long-term growth and quality of earnings, the analysts say. As a result of the cash proceeds and the previous MiExact sale, full-year net cash will increase to GBP63 million, the U.K. brokerage says. Shares are up 2% at 359.00 pence.(najat.kantouar@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 26, 2024 04:31 ET (08:31 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}